Therapeutics, Clinical Trials, FDA Corey Hubbard Therapeutics, Clinical Trials, FDA Corey Hubbard

Unpacking PulseSight's Pioneering Trial for Dry AMD and Geographic Atrophy

Our eyes are windows to the world, allowing us to experience the vibrant tapestry of life. However, certain conditions can threaten this precious sense, leading to significant vision loss. Among the most common causes of vision impairment in older adults are dry Age-related Macular Degeneration (AMD) and its advanced form, Geographic Atrophy (GA)

Read More